课题基金 / 基金详情

Antigen presentation, recognition and the immune response

Antigen presentation, recognition and the immune response
抗原呈递、识别和免疫反应
批准号:
nhmrc : 1113293
负责人:
Prof Andrew Brooks
金额:
$1020.57万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Program Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2021-12-31

项目摘要

项目成果

Prof Andrew Brooks的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This program focuses on understanding the development of immunity during infection or inflammatory diseases using a broad array of techniques to dissect the function of various immune cell types and to explore the relationship between structure and function of important cell surface molecules. These studies will improve our ability to design new generation vaccines for combating infectious diseases, controlling cancer, or limiting autoimmune or inflammatory diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Leukocyte Antigen-A and -B regulation of Natural Killer cell function
  • 批准号:
    DP230103117
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $57.06万
  • 财政年份:
    2023
  • 负责人:
    Prof Andrew Brooks
  • 依托单位:
Antigen presentation, recognition and the immune response
  • 批准号:
    nhmrc : GNT1113293
  • 项目类别:
    Programs
  • 资助金额:
    $1492.7万
  • 财政年份:
    2017
  • 负责人:
    Prof Andrew Brooks
  • 依托单位:
Antigen presentation, recognition and the immune response
  • 批准号:
    nhmrc : 1016629
  • 项目类别:
    Program Grants
  • 资助金额:
    $1052.27万
  • 财政年份:
    2012
  • 负责人:
    Prof Andrew Brooks
  • 依托单位:
Antigen presentation, recognition and the immune response
  • 批准号:
    nhmrc : 454465
  • 项目类别:
    Programs
  • 资助金额:
    $1049.46万
  • 财政年份:
    2007
  • 负责人:
    Prof Andrew Brooks
  • 依托单位:
国内基金
海外基金
基于短寿蛋白肿瘤疫苗诱导的抗瘤作用及其机制的研究
  • 批准号:
    30771999
  • 项目类别:
    面上项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2007
  • 负责人:
    王立新
  • 依托单位: